Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ORMP
#3756
Oramed Pharmaceuticals Inc. - Common Stock
4.0
0
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.01%
Monthly Change
+4.71%
6 month change
+15.27%
Year Change
+89.57%
Previous Close
3.9
6
Open
4.0
0
Low
4.0
0
High
4.0
0
Volume
30
Markets
US Stock Market
Healthcare
Biotechnology
ORMP
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
40.85 M
41 M
39.8 M
40.45 M
40.93 M
40.93 M
Valuation ratios
Enterprise value
86.5 M
75.52 M
51.95 M
69.32 M
125.95 M
160.32 M
Price to earnings ratio
-3.01
-3.63
2.67
1.9
1.31
1.63
Price to sales ratio
44.11
46.38
54.42
60.45
—
—
Price to cash flow ratio
8.38
6.26
10.43
-13.22
-16.88
-21.05
Price to book ratio
0.14
0.16
0.17
0.61
0.18
0.23
Enterprise value to EBITDA ratio
-10.49
-11.44
-7.46
-7.86
-30.5
-38.82
Profitability ratios
Return on assets %
-0.05
0.08
0.22
0.04
0.14
0.14
Return on equity %
-0.05
0.09
0.24
0.05
0.16
0.16
Return on invested capital %
-18.73
-11.9
-9.29
-23.64
-7.18
-7.18
Gross margin %
0.65
—
—
—
—
—
Operating margin %
-225
—
—
—
—
—
EBITDA margin %
-122.2
—
—
—
—
—
Net margin %
-382.1
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
23.94
26.81
22.24
6.98
6.45
6.45
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0.01
0
0
Long term debt to total equity ratio
0
0
0
0.01
0
0
Per share metrics
Operating cash flow per share
-0.09
-0.08
-0.04
-0.01
-0.07
-0.2
EBIT per share
-0.06
-0.03
-0.03
-0.09
0.05
-0.1
EBITDA per share
-0.06
-0.03
-0.03
-0.09
0.05
-0.1
Total debt per share
—
—
—
—
—
—
Cash per share
0.71
1.76
3.05
2.71
1.3
1.3
Net current asset value per share
3.19
2.32
3.18
3.14
1.62
1.62
Tangible book value per share
3.42
3.63
4.75
4.71
5.7
5.7
Working capital per share
3.06
2.24
3.04
2.69
1.37
1.37
Book value per share
3.42
3.63
4.75
4.71
5.7
5.7
News
Oramed: Oral Insulin Drug Failure Pivot, New Strategic Investment Direction (ORMP)
Scilex Holding files lawsuit alleging securities fraud in California court
Oramed stock rises after receiving $18 million payment from Scilex
Oramed receives $18 million payment from Scilex, declares dividend
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years
Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex
Scilex Holding Co sells shares worth $12.7 million
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback
Oramed Pharmaceuticals repurchases shares and ends joint venture with HTIT
Oramed to launch new oral insulin trial after terminating joint venture
Oramed Pharmaceuticals stockholders approve incentive plan amendment, re-elect directors